Cargando…
Leveraging Metabolomics to Assess the Next Generation of Temozolomide-based Therapeutic Approaches for Glioblastomas
Glioblastoma multiforme (GBM) is the most common adult primary tumor of the central nervous system. The current standard of care for glioblastoma patients involves a combination of surgery, radiotherapy and chemotherapy with the alkylating agent temozolomide. Several mechanisms underlying the inhere...
Autores principales: | St-Coeur, Patrick-Denis, Touaibia, Mohamed, Cuperlovic-Culf, Miroslava, Morin, Pier Jr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357826/ https://www.ncbi.nlm.nih.gov/pubmed/23732626 http://dx.doi.org/10.1016/j.gpb.2013.04.003 |
Ejemplares similares
-
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
por: Cuperlovic-Culf, Miroslava, et al.
Publicado: (2014) -
Metabolic Effect of Estrogen Receptor Agonists on Breast Cancer Cells in the Presence or Absence of Carbonic Anhydrase Inhibitors
por: Belkaid, Anissa, et al.
Publicado: (2016) -
Analysis and Simulation of Glioblastoma Cell Lines-Derived Extracellular Vesicles Metabolome
por: Čuperlović-Culf, Miroslava, et al.
Publicado: (2020) -
SMILE: systems metabolomics using interpretable learning and evolution
por: Sha, Chengyuan, et al.
Publicado: (2021) -
Machine Learning Methods for Analysis of Metabolic Data and Metabolic Pathway Modeling
por: Cuperlovic-Culf, Miroslava
Publicado: (2018)